Record-Breaking Revenue and Growth
The company delivered its highest quarterly revenue in history, totaling $23.4 million, marking a 9% growth from the previous year. Gross margins also reached an all-time high at 64%.
Successful Large Enterprise Deal
Closed a large enterprise-wide deal with one of the top 5 most recognized health systems globally. Full deployment in every department and campus is underway.
Butterfly Garden Progress
Added two new Butterfly Garden partners, with FDA clearance received for three applications. HeartFocus is expected to launch in the third quarter, marking the entry into the commercial phase.
Positive Impact of Octiv
Octiv continues to positively impact top and bottom lines, with partnerships leading to increased technology awareness and potential new revenue streams.
Compass AI Launch
Announcement of a new software platform, Compass AI, aimed at reducing documentation steps and increasing penetration within existing customers.
Significant Improvement in Adjusted EBITDA
Adjusted EBITDA loss improved by 24% compared to the previous year, driven by higher revenue and improved gross profit.